Cardlytics Statistics
Total Valuation
Cardlytics has a market cap or net worth of GBP 60.87 million. The enterprise value is 183.87 million.
Market Cap | 60.87M |
Enterprise Value | 183.87M |
Important Dates
The next estimated earnings date is Wednesday, August 6, 2025.
Earnings Date | Aug 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 52.50M |
Shares Outstanding | n/a |
Shares Change (YoY) | +29.85% |
Shares Change (QoQ) | +1.68% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 45.54M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.29 |
PB Ratio | 1.23 |
P/TBV Ratio | n/a |
P/FCF Ratio | 74.41 |
P/OCF Ratio | 37.68 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.33 |
EV / Sales | 0.93 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 224.75 |
Financial Position
The company has a current ratio of 1.19, with a Debt / Equity ratio of 3.44.
Current Ratio | 1.19 |
Quick Ratio | 1.15 |
Debt / Equity | 3.44 |
Debt / EBITDA | n/a |
Debt / FCF | 208.82 |
Interest Coverage | -6.83 |
Financial Efficiency
Return on equity (ROE) is -135.48% and return on invested capital (ROIC) is -10.96%.
Return on Equity (ROE) | -135.48% |
Return on Assets (ROA) | -8.78% |
Return on Invested Capital (ROIC) | -10.96% |
Return on Capital Employed (ROCE) | -27.78% |
Revenue Per Employee | 479,501 |
Profits Per Employee | -313,661 |
Employee Count | 454 |
Asset Turnover | 0.58 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.08% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -79.08% |
50-Day Moving Average | 1.75 |
200-Day Moving Average | 2.94 |
Relative Strength Index (RSI) | 52.24 |
Average Volume (20 Days) | 26,803 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 8.37 |
Income Statement
In the last 12 months, Cardlytics had revenue of GBP 210.98 million and -138.01 million in losses. Loss per share was -2.74.
Revenue | 210.98M |
Gross Profit | 89.13M |
Operating Income | -51.00M |
Pretax Income | -138.01M |
Net Income | -138.01M |
EBITDA | -31.09M |
EBIT | -51.00M |
Loss Per Share | -2.74 |
Balance Sheet
The company has 40.28 million in cash and 170.84 million in debt, giving a net cash position of -130.56 million.
Cash & Cash Equivalents | 40.28M |
Total Debt | 170.84M |
Net Cash | -130.56M |
Net Cash Per Share | n/a |
Equity (Book Value) | 49.61M |
Book Value Per Share | 0.95 |
Working Capital | 19.33M |
Cash Flow
In the last 12 months, operating cash flow was 1.62 million and capital expenditures -797,210, giving a free cash flow of 818,107.
Operating Cash Flow | 1.62M |
Capital Expenditures | -797,210 |
Free Cash Flow | 818,107 |
FCF Per Share | n/a |
Margins
Gross margin is 42.25%, with operating and profit margins of -24.17% and -65.41%.
Gross Margin | 42.25% |
Operating Margin | -24.17% |
Pretax Margin | -65.41% |
Profit Margin | -65.41% |
EBITDA Margin | -14.73% |
EBIT Margin | -24.17% |
FCF Margin | 0.39% |
Dividends & Yields
Cardlytics does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -29.85% |
Shareholder Yield | n/a |
Earnings Yield | -226.72% |
FCF Yield | 1.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Cardlytics has an Altman Z-Score of -4.19 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -4.19 |
Piotroski F-Score | 4 |